Lymphoproliferative disorders associated with hypereosinophilia

Seminars in Hematology

Volumn 49, Issue 2, 2012, Pages 138-148

  Roufosse, Florence ^a   Garaud, Soizic ^b   De Leval, Laurence ^c  

^a ERASME HOSPITAL   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; STAT4 PROTEIN; T LYMPHOCYTE ANTIGEN; TRANSCRIPTION FACTOR GATA 3;

ANGIOIMMUNOBLASTIC T CELL LYMPHOMA; ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; BLOOD DYSCRASIA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL CLONE; CELL EXPANSION; CELL FUNCTION; CELL INFILTRATION; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CYTOKINE PRODUCTION; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; ENTEROPATHY ASSOCIATED T CELL LYMPHOMA; EOSINOPHIL COUNT; GENE REARRANGEMENT; HODGKIN DISEASE; HUMAN; HYPEREOSINOPHILIA; IMMUNOGLOBULIN BLOOD LEVEL; LARGE CELL LYMPHOMA; LYMPHADENOPATHY; LYMPHATIC LEUKEMIA; LYMPHOCYTE PROLIFERATION; LYMPHOPROLIFERATIVE DISEASE; MYCOSIS FUNGOIDES; ONSET AGE; PATHOGENESIS; PERIPHERAL T CELL LYMPHOMA; PRE B LYMPHOCYTE; PRE T LYMPHOCYTE; PRIORITY JOURNAL; SEZARY SYNDROME; T CELL LEUKEMIA; T CELL LYMPHOMA; TH1 CELL; TH1 TH2 BALANCE; TH2 CELL;

ANIMALS; HUMANS; HYPEREOSINOPHILIC SYNDROME; LEUKOPOIESIS; LYMPHOPROLIFERATIVE DISORDERS;

EID: 84858765895     PISSN: 00371963     EISSN: 15328686     Source Type: Journal    
DOI: 10.1053/j.seminhematol.2012.01.003     Document Type: Article

References (83)

1. Roufosse F., Weller P.F. Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol 2010, 126:39-44.
2. Romagnani S. T-cell subsets (Th1 versus Th2). Ann Allergy Asthma Immunol 2000, 85:9-21.
3. Pandit R., Scholnik A., Wulfekuhler L., Dimitrov N. Non-small-cell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome. Am J Hematol 2007, 82:234-237.
4. Blanchard C., Rothenberg M.E. Biology of the eosinophil. Adv Immunol 2009, 101:81-121.
5. Ogbogu P.U., Rosing D.R., Horne M.K. Cardiovascular manifestations of hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007, 27:457-475.
6. Gutierrez A., Solano C., Ferrandez A., et al. Peripheral T-cell lymphoma associated consecutively with hemophagocytic lymphohistiocytosis and hypereosinophilic syndrome. Eur J Haematol 2003, 71:303-306.
7. Bain B.J., Fletcher S.H. Chronic eosinophilic leukemias and the myeloproliferative variant of the hypereosinophilic syndrome. Immunol Allergy Clin North Am 2007, 27:377-388.
8. Kim E.J., Hess S., Richardson S.K., et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest 2005, 115:798-812.
9. Shimauchi T., Sugita K., Nakamura M., Tokura Y. Leukaemic cutaneous T-cell lymphoma-manifesting papuloerythroderma with CD3(-) CD4(+) phenotype. Acta Derm Venereol 2010, 90:68-72.
10. Sausville E.A., Eddy J.L., Makuch R.W., et al. Histopathologic staging at initial diagnosis of mycosis fungoides and the Sezary syndrome. Definition of three distinctive prognostic groups. Ann Intern Med 1988, 109:372-382.
11. Ionescu M.A., Rivet J., Daneshpouy M., Briere J., Morel P., Janin A. In situ eosinophil activation in 26 primary cutaneous T-cell lymphomas with blood eosinophilia. J Am Acad Dermatol 2005, 52:32-39.
12. Tancrede-Bohin E., Ionescu M.A., de La Salmoniere P., et al. Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas. Arch Dermatol 2004, 140:1057-1061.
13. Vowels B.R., Cassin M., Vonderheid E.C., Rook A.H. Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 1992, 99:90-94.
14. Vowels B.R., Lessin S.R., Cassin M., et al. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma. J Invest Dermatol 1994, 103:669-673.
15. Showe L.C., Fox F.E., Williams D., Au K., Niu Z., Rook A.H. Depressed IL-12-mediated signal transduction in T cells from patients with Sezary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4. J Immunol 1999, 163:4073-4079.
16. Dummer R., Heald P.W., Nestle F.O., et al. Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood 1996, 88:1383-1389.
17. Sleigh K.A., Smith M.E., Rule S.A. Cardiac involvement with mycosis fungoides: could this explain alemtuzumab toxicity?. Leuk Lymphoma 2008, 49:2022-2024.
18. Lee C.H., Mamelak A.J., Vonderheid E.C. Erythrodermic cutaneous T cell lymphoma with hypereosinophilic syndrome: treatment with interferon alfa and extracorporeal photopheresis. Int J Dermatol 2007, 46:1198-1204.
19. Miyagaki T., Sugaya M., Fujita H., et al. Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma. J Invest Dermatol 2010, 130:2304-2311.
20. Kakinuma T., Sugaya M., Nakamura K., et al. Thymus and activation-regulated chemokine (TARC/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides. J Am Acad Dermatol 2003, 48:23-30.
21. Vose J., Armitage J., Weisenburger D. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008, 26:4124-4130.
22. Mourad N., Mounier N., Briere J., et al. Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d'Etude des Lymphomes de l'Adulte (GELA) trials. Blood 2008, 111:4463-4470.
23. de Leval L., Gisselbrecht C., Gaulard P. Advances in the understanding and management of angioimmunoblastic T-cell lymphoma. Br J Haematol 2009, 148:673-689.
24. Merchant S.H., Amin M.B., Viswanatha D.S. Morphologic and immunophenotypic analysis of angioimmunoblastic T-cell lymphoma: emphasis on phenotypic aberrancies for early diagnosis. Am J Clin Pathol 2006, 126:29-38.
25. Gaulard P., de Leval L. Follicular helper T cells: implications in neoplastic hematopathology. Semin Diagn Pathol 2011, 28:202-213.
26. Thielen C., Radermacher V., Trimeche M., et al. TARC and IL-5 expression correlates with tissue eosinophilia in peripheral T-cell lymphomas. Leuk Res 2008, 32:1431-1438.
27. Ohshima K.S., Suzumiya J., Kawasaki C., Kanda M., Kikuchi M. Cytoplasmic cytokines in lymphoproliferative disorders: multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia. Leuk Lymphoma 2000, 38:541-545.
28. Genovesi-Ebert A., Lombardi M., Capochiani E., et al. Heart involvement in T cell lymphoma through hypereosinophilic syndrome: a common complication of a rare condition. J Cardiovasc Magn Reson 2005, 7:495-499.
29. Matutes E. Adult T-cell leukaemia/lymphoma. J Clin Pathol 2007, 60:1373-1377.
30. Tian Y., Kobayashi S., Ohno N., et al. Leukemic T cells are specifically enriched in a unique CD3(dim) CD7(low) subpopulation of CD4(+) T cells in acute-type adult T-cell leukemia. Cancer Sci 2011, 102:569-577.
31. Murata K., Yamada Y., Kamihira S., et al. Frequency of eosinophilia in adult T-cell leukemia/lymphoma. Cancer 1992, 69:966-971.
32. Utsunomiya A., Ishida T., Inagaki A., et al. Clinical significance of a blood eosinophilia in adult T-cell leukemia/lymphoma: a blood eosinophilia is a significant unfavorable prognostic factor. Leuk Res 2007, 31:915-920.
33. Noma T., Nakakubo H., Sugita M., et al. Expression of different combinations of interleukins by human T cell leukemic cell lines that are clonally related. J Exp Med 1989, 169:1853-1858.
34. Ogata M., Ogata Y., Kohno K., et al. Eosinophilia associated with adult T-cell leukemia: role of interleukin 5 and granulocyte-macrophage colony-stimulating factor. Am J Hematol 1998, 59:242-245.
35. Yano A., Yasukawa M., Yanagisawa K., et al. Adult T cell leukemia associated with eosinophilia: analysis of eosinophil-stimulating factors produced by leukemic cells. Acta Haematol 1992, 88:207-212.
36. Nimer S.D., Gasson J.C., Hu K., et al. Activation of the GM-CSF promoter by HTLV-I and -II tax proteins. Oncogene 1989, 4:671-676.
37. Yamagata T., Mitani K., Ueno H., Kanda Y., Yazaki Y., Hirai H. Triple synergism of human T-lymphotropic virus type 1-encoded tax, GATA-binding protein, and AP-1 is required for constitutive expression of the interleukin-5 gene in adult T-cell leukemia cells. Mol Cell Biol 1997, 17:4272-4281.
38. Vukelja S.J., Weiss R.B., Perry D.J., Longo D.L. Eosinophilia associated with adult T-cell leukemia/lymphoma. Cancer 1988, 62:1527-1530.
39. + lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators. J Cutan Pathol 2006, 33(Suppl 1):58-70.
40. McCluggage W.G., Walsh M.Y., Bharucha H. Anaplastic large cell malignant lymphoma with extensive eosinophilic or neutrophilic infiltration. Histopathology 1998, 32:110-115.
41. Aractingi S., Bachmeyer C., Pautier P., et al. Necrotic cutaneous lesions induced by hypereosinophilic syndrome secondary to a T-cell lymphoma. J Am Acad Dermatol 2002, 46(5 Suppl):S133-S136.
42. Powers M.L., Watson B.W., Frater J.L., Kreisel F., Hassan A. Peripheral eosinophilia camouflaging anaplastic large cell lymphoma. Int J Surg Pathol 2011, 19:405-408.
43. Massone C., El-Shabrawi-Caelen L., Kerl H., Cerroni L. The morphologic spectrum of primary cutaneous anaplastic large T-cell lymphoma: a histopathologic study on 66 biopsy specimens from 47 patients with report of rare variants. J Cutan Pathol 2008, 35:46-53.
44. Kong Y.Y., Dai B., Kong J.C., Lu H.F., Shi D.R. Neutrophil/eosinophil-rich type of primary cutaneous anaplastic large cell lymphoma: a clinicopathological, immunophenotypic and molecular study of nine cases. Histopathology 2009, 55:189-196.
45. + cutaneous T-cell lymphoma. Blood 2003, 101:1487-1493.
46. Whittaker S.J., Jones R.R., Spry C.J. Lymphomatoid papulosis and its relationship to "idiopathic" hypereosinophilic syndrome. J Am Acad Dermatol 1988, 18:339-344.
47. McPherson T., Cowen E.W., McBurney E., Klion A.D. Platelet-derived growth factor receptor-alpha-associated hypereosinophilic syndrome and lymphomatoid papulosis. Br J Dermatol 2006, 155:824-826.
48. Thuny C., Gaudy-Marqueste C., Nicol I., et al. Chronic eosinophilic leukaemia revealed by lymphomatoid papulosis: the role of the FIP1-like 1-platelet-derived growth factor receptor alpha fusion gene. J Eur Acad Dermatol Venereol 2010, 24:234-235.
49. Yagi H., Tokura Y., Furukawa F., Takigawa M. Th2 cytokine mRNA expression in primary cutaneous CD30-positive lymphoproliferative disorders: successful treatment with recombinant interferon-gamma. J Invest Dermatol 1996, 107:827-832.
50. Gallamini A., Carbone A., Lista P., et al. Intestinal T-cell lymphoma with massive tissue and blood eosinophilia mediated by IL-5. Leuk Lymphoma 1995, 17:155-161.
51. Shepherd N.A., Blackshaw A.J., Hall P.A., et al. Malignant lymphoma with eosinophilia of the gastrointestinal tract. Histopathology 1987, 11:115-130.
52. Hovenga S., de Graaf H., Joosten P., et al. Enteropathy-associated T-cell lymphoma presenting with eosinophilia. Neth J Med 2003, 61:25-27.
53. Savage K.J., Ferreri A.J., Zinzani P.L., Pileri S.A. Peripheral T-cell lymphoma-not otherwise specified. Crit Rev Oncol Hematol 2010, 79:321-329.
54. Matsumoto Y., Horiike S., Ohshiro M., et al. Expression of master regulators of helper T-cell differentiation in peripheral T-cell lymphoma, not otherwise specified, by immunohistochemical analysis. Am J Clin Pathol 2010, 133:281-290.
55. Kawasaki A., Mizushima Y., Matsui S., Hoshino K., Yano S., Kitagawa M. A case of T-cell lymphoma accompanying marked eosinophilia, chronic eosinophilic pneumonia and eosinophilic pleural effusion. A case report. Tumori 1991, 77:527-530.
56. Roufosse F., Cogan E., Goldman M. Lymphocytic variant hypereosinophilic syndromes. Immunol Allergy Clin North Am 2007, 27:389-413.
57. Vaklavas C., Tefferi A., Butterfield J., et al. 'Idiopathic' eosinophilia with an Occult T-cell clone: prevalence and clinical course. Leuk Res 2007, 31:691-694.
58. Simon H.U., Plotz S.G., Dummer R., Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med 1999, 341:1112-1120.
59. - T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 1996, 183:1071-1082.
60. Schandene L., Roufosse F., de Lavareille A., et al. Interferon alpha prevents spontaneous apoptosis of clonal Th2 cells associated with chronic hypereosinophilia. Blood 2000, 96:4285-4292.
61. + T-cell clones associated with the lymphocytic variant of hypereosinophilic syndrome. Haematologica 2005, 90:753-765.
62. + T cells from patients with the lymphocytic variant of hypereosinophilic syndrome reveals targeting of growth control pathways. Blood 2009, 114:2969-2983.
63. Gniadecki R., Lukowsky A. Monoclonal T-cell dyscrasia of undetermined significance associated with recalcitrant erythroderma. Arch Dermatol 2005, 141:361-367.
64. Watanabe K., Shinbo T., Kojima M., Naito M., Tanahashi N., Nara M. B-cell lymphoma associated with eosinophilia. Cancer 1989, 64:1682-1685.
65. Rapanotti M.C., Caruso R., Ammatuna E., et al. Molecular characterization of paediatric idiopathic hypereosinophilia. Br J Haematol 2010, 151:440-446.
66. Farrell K., Jarrett R.F. The molecular pathogenesis of Hodgkin lymphoma. Histopathology 2011, 58:15-25.
67. Teruya-Feldstein J., Jaffe E.S., Burd P.R., Kingma D.W., Setsuda J.E., Tosato G. Differential chemokine expression in tissues involved by Hodgkin's disease: direct correlation of eotaxin expression and tissue eosinophilia. Blood 1999, 93:2463-2470.
68. Niens M., Visser L., Nolte I.M., et al. Serum chemokine levels in Hodgkin lymphoma patients: highly increased levels of CCL17 and CCL22. Br J Haematol 2008, 140:527-536.
69. van den Berg A., Visser L., Poppema S. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma. Am J Pathol 1999, 154:1685-1691.
70. Vaughan Hudson B., Linch D.C., Macintyre E.A., et al. Selective peripheral blood eosinophilia associated with survival advantage in Hodgkin's disease (BNLI Report No 31). British National Lymphoma Investigation. J Clin Pathol 1987, 40:247-250.
71. Samoszuk M., Nansen L. Detection of interleukin-5 messenger RNA in Reed-Sternberg cells of Hodgkin's disease with eosinophilia. Blood 1990, 75:13-16.
72. Di Biagio E., Sanchez-Borges M., Desenne J.J., Suarez-Chacon R., Somoza R., Acquatella G. Eosinophilia in Hodgkin's disease: a role for interleukin 5. Int Arch Allergy Immunol 1996, 110:244-251.
73. Stanelle J., Doring C., Hansmann M.L., Kuppers R. Mechanisms of aberrant GATA3 expression in classical Hodgkin lymphoma and its consequences for the cytokine profile of Hodgkin and Reed/Sternberg cells. Blood 2010, 116:4202-4211.
74. von Wasielewski R., Seth S., Franklin J., et al. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin's disease, allowing for known prognostic factors. Blood 2000, 95:1207-1213.
75. Yalonetsky S., Mishaly D., Ben-Barak A., Lorber A. Mitral valve destruction by Hodgkin's lymphoma-associated Loefler endocarditis. Pediatr Cardiol 2008, 29:983-985.
76. Fishel R.S., Farnen J.P., Hanson C.A., Silver S.M., Emerson S.G. Acute lymphoblastic leukemia with eosinophilia. Medicine (Baltimore) 1990, 69:232-243.
77. Hogan T.F., Koss W., Murgo A.J., Amato R.S., Fontana J.A., VanScoy F.L. Acute lymphoblastic leukemia with chromosomal 5;14 translocation and hypereosinophilia: case report and literature review. J Clin Oncol 1987, 5:382-390.
78. Spitzer G., Garson O.M. Lymphoblastic leukemia with marked eosinophilia: a report of two cases. Blood 1973, 42:377-384.
79. Sutton R., Lonergan M., Tapp H., et al. Two cases of hypereosinophilia and high-risk acute lymphoblastic leukemia. Leukemia 2008, 22:1463-1465.
80. Meeker T.C., Hardy D., Willman C., Hogan T., Abrams J. Activation of the interleukin-3 gene by chromosome translocation in acute lymphocytic leukemia with eosinophilia. Blood 1990, 76:285-289.
81. Bhatti F.A., Hussain I., Ali M.Z. Adult B lymphoblastic leukaemia/lymphoma with hypodiploidy (-9) and a novel chromosomal translocation t(7;12)(q22;p13) presenting with severe eosinophilia-case report and review of literature. J Hematol Oncol 2009, 2:26.
82. Troxell M.L., Mills G.M., Allen R.C. The hypereosinophilic syndrome in acute lymphocytic leukemia. Cancer 1984, 54:1058-1061.
83. Files M.D., Zenel J.A., Armsby L.B., Langley S.M. A child with eosinophilia, Loeffler endocarditis, and acute lymphoblastic leukemia. Pediatr Cardiol 2009, 30:530-532.